Biotech · Private company
RyCarma Therapeutics, Inc.
Track this companyFree. Adds RyCarma Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- S48168 (ARM210)Phase 2 · Catecholaminergic Polymorphic Ventricular Tachycardia Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- S48168Phase 1 · RYR-1 MyopathyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Treatment of an Inherited Ventricular ArrhythmiaPHASE2 · TERMINATED · started Aug 1, 2023ClinicalTrials.gov NCT05122975 · fetched Nov 12, 2026
- S 48168 (ARM 210) for the Treatment of RYR1-related Myopathies (RYR1-RM)PHASE1 · COMPLETED · started Aug 25, 2020ClinicalTrials.gov NCT04141670 · fetched Nov 12, 2026